Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001178913-13-000933
Filing Date
2013-03-29
Accepted
2013-03-29 09:30:56
Documents
1
Effectiveness Date
2013-03-29

Document Format Files

Seq Description Document Type Size
1 DEFA 14A zk1312888.htm DEFA14A 46113
  Complete submission text file 0001178913-13-000933.txt   47376
Mailing Address MATAM ADVANCED TECHNOLOGY PARK BUILDING NO. 5 HAIFA L3 31905
Business Address MATAM ADVANCED TECHNOLOGY PARK BUILDING NO. 5 HAIFA L3 31905 972-74-710-7171
PLURISTEM THERAPEUTICS INC (Filer) CIK: 0001158780 (see all company filings)

EIN.: 980351734 | State of Incorp.: NV | Fiscal Year End: 0630
Type: DEFA14A | Act: 34 | File No.: 001-31392 | Film No.: 13726376
SIC: 2836 Biological Products, (No Diagnostic Substances)